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Recent studies of immunity to intracellular bacterial
pathogens demonstrate the complex role of bacterial
protein secretion in the activation and function of
protective T lymphocytes in vivo.
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Most eukaryotic cells express major histocompatibility
complex (MHC) class I molecules on their surface. These
immune molecules present peptide fragments derived
from the breakdown of proteins in the cell to CD8+ cyto-
toxic T lymphocytes (CTLs), which recognize the
peptide–MHC complexes via T-cell receptors (TCRs)
expressed on their surface [1]. In uninfected cells, the
peptides that are bound within the cleft of MHC class I
molecules are derived from self-encoded proteins and do
not activate the CTLs. During infection, however, some
of the peptides that are presented on the cell surface by
MHC class I molecules derive from intracellular
pathogens. These peptides are recognized by CTLs as
being foreign, thereby inducing activation, proliferation
and expansion of these cells into an effector population
that can directly combat infection and also give rise to
memory CTLs that rapidly curtail repeat infections with
the same pathogen. A critical aspect of this process is that
CTLs only recognize foreign peptides that are presented
by self-MHC class I molecules, hence the concept of
MHC restriction [2].
Much has been learned in the past decade about the intra-
cellular mechanisms involved in the presentation of pep-
tides by MHC class I molecules. Most MHC class I
associated peptides are derived from proteasome-medi-
ated degradation of cytosolic proteins [3]. Proteasomes are
complex, multisubunit proteases that generate peptides of
an appropriate length for association with MHC class I
molecules. Cytosolic peptides are transported via an ATP-
dependent process into the endoplasmic reticulum by the
transporter associated with antigen processing (TAP), a
heterodimeric transporter protein. Newly synthesized,
‘empty’ MHC class I molecules associate with TAP and
bind the peptides transported by this protein [1]. Upon
peptide binding, MHC class I molecules dissociate from
TAP, traverse the Golgi complex and move to the cell
surface. The majority of MHC class I antigen processing is
dependent upon proteasome and TAP function. 
Even before there was any clear understanding of the
antigen-processing pathways, investigations by Bevan [4]
demonstrated that antigen presentation in vivo need not
follow the conventional pathway. These early studies
demonstrated that T cells could respond to peptides
derived from cells that did not express the restricting MHC
molecule. This process was called cross-priming, because it
was correctly assumed that antigen was being transferred
from the immunizing cells, which lacked the restricting
MHC class I molecule, to host cells which did express the
restricting MHC class I molecule. This and subsequent
work pointed towards the existence of cells that could
present antigen by taking up exogenous cellular material
and feeding it into the MHC class I antigen-processing
pathway. Indeed, studies of tumor-specific immunity have
demonstrated that cross-priming plays a major role in the
generation of CTLs that recognize tumor-specific antigens
[5]. Recent studies suggest that cross-priming may be the
major pathway for CTL priming [6]. Interestingly, cross-
priming appears to be highly dependent on the interaction
of both antigen-specific CD4+ and CD8+ T lymphocytes
with the same individual antigen-presenting cell (APC).
Although exogenous soluble antigens do not access the
MHC class I antigen-processing pathway, CTLs efficiently
recognize peptide–MHC complexes on macrophages that
have phagocytosed antigen-coated particles [7]. Interest-
ingly, this particulate MHC class I antigen-presentation
pathway and the in vivo cross-priming process are both
TAP dependent, indicating that exogenous antigens are
entering the cytosol of the APC [5,7].
A number of bacterial pathogens escape antibody-medi-
ated immune defenses by entering cells. One such
pathogen is the Gram-positive bacterium Listeria monocyto-
genes, which is phagocytosed by macrophages and enters
the cytosol by secreting the protein listeriolysin, which
lyses cell membranes. Some of the proteins that L. monocy-
togenes secretes into the host cell cytosol are degraded by
proteasomes into peptides that then become bound by
MHC class I molecules. Infection with L. monocytogenes
elicits a robust CTL response in mice that is specific for
many different secreted proteins and peptides [8]. Entry
of L. monocytogenes into the cytosol is essential for the pre-
sentation of antigens to CTL [9]. Indeed, immunization
with bacteria that lack listeriolysin does not result in pro-
tective immunity [10]. Remarkably, all of the MHC class I
restricted L. monocytogenes epitopes that have been identi-
fied so far are either secreted peptides or derive from
secreted proteins [8]. Although secreted proteins account
for only 1–2% of total bacterial protein synthesis [11], they
are the target of more than 70% of the MHC class I
restricted CTL response to L. monocytogenes infection [12].
These findings suggest that secreted proteins have a
selective advantage when it comes to priming CTLs
during bacterial infection.
The first study to directly address the role of antigen
secretion in the generation of protective immunity was
performed by Hess, Kaufmann and colleagues [13]. They
expressed two L. monocytogenes antigens, listeriolysin and
p60, in Salmonella typhimurium as secreted or non-secreted
forms. Mice immunized with S. typhimurium expressing
the secreted forms of these antigens were protected
against future L. monocytogenes infection, whereas immu-
nization with S. typhimurium expressing the non-secreted
antigens did not induce protective immunity. Interest-
ingly, the protective immunity that resulted from immu-
nization with recombinant S. typhimurium involved both
CD4+ and CD8+ T lymphocytes. This finding is remark-
able, because S. typhimurium remains confined to an intra-
cellular vacuole and is unable to directly access the MHC
class I antigen-processing pathway.
The two antigens that were used in this study, p60 and lis-
teriolysin, are both secreted by L. monocytogenes. To deter-
mine whether secreted antigens are exclusively the targets
of protective immunity, Hess and colleagues next engi-
neered a secretable version of the non-secreted L. monocy-
togenes protein superoxide dismutase (SOD), expressed
this protein in S. typhimurium and immunized mice with
this recombinant bacterium [14]. Surprisingly, mice were
protected from L. monocytogenes infection, again by both
CD4+ and CD8+ T lymphocytes. Thus, although antigen
secretion by S. typhimurium is critical for the induction of
protective immunity, antigen secretion by the target of the
protective immune response, in this case L. monocytogenes,
appears not to be essential.
The role of protein secretion in antigenicity was further
dissected by Shen and colleagues [15], who performed a
careful analysis of the CTL response to a lymphocytic
choriomeningitis virus (LCMV) epitope (NP 118–126,
amino acids 118–126 of the LCMV nucleoprotein) con-
tained within an engineered protein that was either
secreted by L. monocytogenes or retained within the bac-
terium. Care was taken to generate L. monocytogenes strains
that either secreted or retained similar amounts of the
antigen. An important consequence of this manipulation,
however, is that antigen-retaining bacteria carry signifi-
cantly more antigen into host cells than antigen-secreting
bacteria. Nevertheless, mice were infected with these two
strains of bacteria and T-cell responses to NP 118–126
were quantified. Surprisingly, the magnitude of the T-cell
response to the LCMV epitope was similar in mice immu-
nized with either antigen-secreting or antigen-retaining
strains of L. monocytogenes. Importantly, mice immunized
with either strain had equivalent immunity to LCMV
infection, demonstrating that protective immunity could
be induced with a non-secreted antigen.
Although this result appears to contradict the findings with
non-secreted S. typhimurium antigens [13,14], there are
some important differences between the two systems that
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Figure 1
(a) S. typhimurium and (b) L. monocytogenes
(shown as dark pink and dark blue,
respectively) occupy different cellular
compartments in the infected host cell: S.
typhimurium is confined to the membrane-
enclosed vacuole whereas L. monocytogenes
enters the cytosol. The implications for T-cell
responses and protective immunity to
secreted and non-secreted forms of antigens
(represented as coloured rectangles) carried
by these bacteria, as determined by Hess and
colleagues [13,14] and Shen and colleagues
[15], are illustrated. See text for more details.
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may reconcile these disparate results and, perhaps, shed
light on the underlying mechanisms (Figure 1). First, S.
typhimurium resides in the vacuoles of the host cell whereas
L. monocytogenes enters the cytosol of infected cells. Thus,
different subcellular compartmentalization of the antigen-
carrying bacterium may account for the lack of priming with
non-secreted S. typhimurium antigens and efficient priming
with non-secreted L. monocytogenes antigens. Second, S.
typhimurium predominantly infects macrophages whereas L.
monocytogenes infects macrophages, hepatocytes and perhaps
other cells. Thus, priming of CTLs for non-secreted bacter-
ial antigens may require infection of cells that are not ‘pro-
fessional’ APCs. Third, although both of these bacteria are
intracellular pathogens, they differ quite dramatically from
each other. L. monocytogenes is a Gram-positive bacterium
that induces high levels of interleukin-12 production from
macrophages [16], whereas S. typhimurium is a Gram-nega-
tive bacterium that contains lipopolysaccharide and induces
a distinct inflammatory response. It is possible, indeed
likely, that the different inflammatory responses to these
two different pathogens have distinct effects on the priming
and expansion of T cells.
Shen and colleagues [15] also investigated the ability of
CTLs specific for non-secreted antigens to protect
against L. monocytogenes infection. Specifically, mice were
immunized with LCMV, which primes a CTL response
specific for NP 118–126. Immunized mice were then
challenged with L. monocytogenes that either secreted or
retained the engineered NP 118–126 antigen. Mice that
were immune to LCMV resisted infection by antigen-
secreting bacteria, but not by bacteria that retained the
antigen intrabacterially. This finding suggests that
although non-secreted antigens can prime CTLs, these
antigens are not adequately presented to CTLs during
systemic L. monocytogenes infection to play a role in the
clearance of bacteria in vivo.
These findings also appear to contradict those of Hess
and colleagues [13,14], but again there are substantial
differences between the two systems. For example, the
immunizing and challenging antigens differ. In the case
of SOD, this protein antigen expressed in the immuniz-
ing S. typhimurium was the same as that expressed in the
challenging L. monocytogenes and contained both MHC
class I restricted and MHC class II restricted epitopes
[14]. In contrast, the immunizing LCMV and the chal-
lenging L. monocytogenes strain shared only the NP
118–126 epitope (and three flanking amino acids on each
side), essentially limiting the similarity of the two anti-
gens to a single MHC class I restricted epitope [15].
This difference, together with the involvement of both
CD4+ and CD8+ T-cell responses to SOD and only
CD8+ T-cell responses to NP 188–126 may account for
the ability of SOD-specific T cells to protect against 
L. monocytogenes infection. 
Is cross-priming involved in the CTL response to L. mono-
cytogenes infection? More specifically, is the generation of a
CTL response to a non-secreted L. monocytogenes protein
best explained by cross-priming? These questions will
require further work and additional experimental
approaches before the answers become clear. Unlike
studies with antigen-coated particles [7], in the experi-
ments described by Shen et al. [15] the antigen is con-
tained within a Gram-positive bacterium, a rather dramatic
difference. How is a Gram-positive bacterium, which is
enclosed by a thick wall of peptidoglycan, cracked open
and how are internal antigens extracted and processed by
either the conventional or the cross-priming MHC class I
antigen-processing pathways? The answers to these ques-
tions will be very revealing.
The relative role of secreted versus non-secreted proteins
in protective immunity is of significant importance for
vaccine development. The studies by Shen and colleagues
[15] suggest that immunization resulting in a CTL
response specific for a single epitope can be protective
only if the epitope derives from a secreted antigen. Hess
and Kaufmann’s work [13,14], on the other hand, suggests
that if immune responses are targeted against more
complex antigens, even bacterially retained proteins can
contribute to protective immunity. These contrasting
studies provide a foundation for future work exploring the
mechanisms of T-cell priming and should contribute to
the rational design of vaccines.
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If you found this dispatch interesting, you might also want
to read the February 1998 issue of
Current Opinion in
Immunology
which included the following reviews, edited
by R Alan B Ezekowitz and Jules
Hoffmann, on Innate immunity:
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invertebrate immunity
Kenneth Söderhäll and Lage Cerenius
Complement-related serine proteases in tunicates and
vertebrates
Misao Matsushita, Yuichi Endo, Masaru Nonaka and Teizo
Fujita
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Michael C Carroll and Andrey P Prodeus
Antimicrobial peptides of vertebrates
Tomas Ganz and Robert I Lehrer
Role of the bactericidal/permeability-increasing
protein in host defence
Peter Elsbach and Jerrold Weiss
The mannose receptor is a pattern recognition
receptor involved in host defense
Philip D Stahl and R Alan B Ezekowitz
the same issue also included the following
reviews, edited by Hidde Ploegh and Colin
Watts, on Antigen recognition:
The pathogenetic role of HLA-B27 in chronic arthritis
José A López de Castro
Unusual MHC-like molecules: CD1, Fc receptor, the
hemochromatosis gene product, and viral homologs
Ian A Wilson and Pamela J Bjorkman
Conserved motifs in T-cell receptor CDR1 and CDR2:
implications for ligand and CD8 co-receptor binding
Bernard Arden
CD4 and CD8: modulators of T-cell receptor
recognition of antigen and of immune responses? 
Rose Zamoyska
The full text of Current Opinion in Immunology is in the
BioMedNet library at
http://BioMedNet.com/cbiology/imm
